-
Mesothelioma Study Suggests Benefit to Early Immunotherapy Treatment
Mesothelioma researchers continue to search for the best approach to the rare, asbestos-related disease. A recent report indicated that immune checkpoint inhibitors can have a positive impact when administered with chemotherapy prior to surgery.
-
Pennsylvania Supreme Court Decision Thought to Have Strengthened Mesothelioma Claims
Many mesothelioma victims pursue litigation against the asbestos companies that exposed them to the toxic material. Most name multiple defendants whose products contained asbestos or who supplied the carcinogen. When plaintiffs win, the jury apportions the amount of compensation each defendant must pay based on numerous factors. But a decision made in 2020 by the…
-
German Researcher Offers Extended Mesothelioma Survival Using Chemotherapy Via Isolated Thoracic Perfusion
Malignant pleural mesothelioma is a rare and fatal form of cancer caused by exposure to asbestos. The disease is extremely aggressive and has proven challenging to physicians and researchers, who use a combination of surgery, chemotherapy, and radiation to slow its progress. Among those working to find a solution is a man considered one of…
-
Mesothelioma Widow Wins Larger Workers Compensation Payout
More often than not, malignant mesothelioma follows workplace exposure to asbestos, and that means that, in addition to pursuing negligence claims against manufacturers and suppliers, victims and their families may be eligible for workers’ compensation. When a widow in Delaware filed for benefits following her husband’s death, the victim’s former employer pushed back and tried…
-
Peritoneal Mesothelioma Survival Extended with New Surgical Technique
Every day, researchers and physicians are working to find new and better ways to care for mesothelioma patients. A recent report reveals that renowned surgeon Dr. Paul Sugarbaker has identified a new surgical technique that may yield longer survival for patients diagnosed with peritoneal mesothelioma.
-
Goodyear Blamed for Woman’s Asbestos-Related Lung Cancer
Edith Niedert never dreamed that the simple task of washing her husband’s work clothes would lead to being diagnosed with asbestos-related lung cancer. But 40 years of exposure to asbestos dust added up, and now she and her husband have filed suit against Goodyear Tire & Rubber Company, whose gaskets and gasket materials Mr. Niedert…
-
Johnson & Johnson Mesothelioma Victims Win Major Decision in Bankruptcy Case
Cancer victims who blame their malignant mesothelioma and ovarian cancer on exposure to asbestos-contaminated talc in Johnson & Johnson’s Baby Powder won a massive court victory this week. A federal appeals court in Philadelphia rejected the company’s use of a controversial legal maneuver that had first transferred their talc liabilities into a newly formed company…
-
Italian Researchers Reveal Promising Results from Study of HITHOC’s Use in Mesothelioma
Pleural mesothelioma is a notoriously challenging disease. Always considered a terminal diagnosis, the rare form of asbestos-related cancer is also extremely aggressive, claiming its victims’ lives in a painfully short period. To counter this, researchers around the world are working to find therapies that extend life in a way that also improves quality of life.…
-
Do Mesothelioma Cells Change Size to Survive Cancer Treatment?
There’s no mystery as to how malignant mesothelioma gets its start. The rare and fatal form of cancer is caused by exposure to asbestos, often as a result of negligence on the part of manufacturers, suppliers, and employers. But questions remain about how best to treat the cancer, and why it so successfully evades cancer…
-
FDA Grants Permission for Study of New Therapeutic for Malignant Mesothelioma
Malignant mesothelioma is one of several types of cancer that harbors a specific genetic alteration known as an MTAP deletion. This week, the U.S. Food and Drug Administration approved a study looking at a new drug application that specifically binds to cells affected by this alteration.
-
Study Ordered Following Concerning Rise in UK Teacher Mesothelioma Deaths
Following a significant and troubling rise in mesothelioma deaths among women in their late 40s to mid-60s, trade unions in the United Kingdom have ordered a study of the presence of asbestos in the country’s school buildings. There is concern that the increase may be statistically significant among teachers who were exposed to the material.
-
Judge Denies Pump Manufacturer’s Attempt to Evade Mesothelioma Lawsuit
Thomas N. Wixted died of malignant mesothelioma 46 years after leaving his position as senior stationary engineer at the Suffolk State School in New York. His widow, Jane, filed a personal injury lawsuit against Milton Roy, a pump manufacturer that she says provided asbestos-contaminated pipes to which her late husband had been exposed. Though the…
-
Widow’s Asbestos Claim Against Porsche to Continue
In 2020, 79-year-old Francesco Carboni died of asbestos-related lung cancer. His widow Susan filed a personal injury lawsuit against multiple defendants whose asbestos-contaminated parts and materials she blamed for his illness and subsequent death. Among the defendants was Porsche Cars, North America. Though the auto manufacturer argued that they should be dismissed from the case,…
-
Steamfitter with Mesothelioma Wins $23 Million Jury Verdict
Eighty-one-year-old mesothelioma victim James McWilliams blames his fatal illness on decades of exposure to asbestos in the Jenkins Bros. valves he installed throughout New York City as a career steamfitter. He filed a personal injury lawsuit against the company and others, and last month a Manhattan jury found the company guilty and awarded him $23…
-
Philadelphia Couple Awarded $25 Million in Asbestosis Case
After decades of working with a variety of asbestos-contaminated products, Richard Daciw was diagnosed with asbestosis. He and his wife Winifred filed a lawsuit seeking compensation for the damages he suffered, and after hearing testimony about extensive negligence on the part of multiple manufacturers, a Philadelphia jury has awarded the couple $25 million in damages.
-
Protein That Fights the Immune System Plays Key Role in Mesothelioma
Researchers in the United Kingdom have recently discovered how a specific human protein works to help cancer thrive, and their findings may prove helpful in fighting malignant mesothelioma.
-
Veteran’s Mesothelioma Blamed on Asbestos Exposure in Nuclear Submarine
Albert O. Howard was diagnosed with malignant pleural mesothelioma in 2020. He and his wife filed a negligence lawsuit against Armstrong Pumps, blaming them for his exposure to asbestos during the years that he served in the U.S. Navy. Though the company argued that the case against them should be dismissed, their petition was denied…
-
Study Suggests Elevated Suicide Risk Following Mesothelioma Surgery
Despite physicians’ best efforts, the current 5-year survival rate for patients diagnosed with malignant mesothelioma is just ten percent. As bleak as this statistic is, a new study conducted by researchers at Massachusetts General Hospital in Boston has added to caregivers’ concerns: they found a significantly higher risk for suicide among patients undergoing surgery for…
-
Mesothelioma Patients Encouraged by Results of Tumor Treating Fields Study
Tumor treating fields are one of the most promising innovations being offered to patients with malignant mesothelioma. The protocol uses electrical fields to kill cancer cells and was only recently approved for use in treating the rare asbestos-related disease. A study examining tumor treating fields’ effectiveness in treating patients with a different type of cancer…
-
New Research May Reveal How Mesothelioma Metastasizes
Malignant mesothelioma is a rare form of cancer. The disease is characterized by tumors that form in the lining of the lungs or the abdomen. Treatment focuses on removing or minimizing the tumors that are identified and preventing their return or spread. New research has provided greater understanding of how cancer cells metastasize, and may…
